Literature DB >> 1334078

Binding of surfactant protein A (SP-A) to herpes simplex virus type 1-infected cells is mediated by the carbohydrate moiety of SP-A.

J F van Iwaarden1, J A van Strijp, H Visser, H P Haagsman, J Verhoef, L M van Golde.   

Abstract

Pulmonary surfactant protein A (SP-A) has been shown to act as an opsonin in the phagocytosis of viruses by alveolar macrophages. To determine whether SP-A binds to viral proteins and which part of the SP-A molecule is involved in this interaction, binding studies were undertaken. SP-A was labeled with fluorescein isothiocyanate, and its binding to herpes simplex virus type 1-infected HEp-2 cells, as a model for virus-infected cells in general, was studied using flow cytometry. The binding of SP-A to virus-infected cells was saturable, reversible, and both time- and concentration-dependent, reaching a maximal level after 30 min at an SP-A concentration of 10 micrograms/ml. An approximately 4-fold increase in binding of SP-A to infected cells over control cells was observed. Yeast mannan, a mannose homopolysaccharide, did not influence the binding. However, heparin inhibited binding of SP-A in a concentration-dependent manner. In addition, heparin could also dissociate cell-bound SP-A, indicating that polyanionic oligosaccharides are involved in the binding of SP-A to virus-infected cells. Deglycosylated SP-A, obtained by digestion with N-glycosidase F, did not bind to infected cells. Heparin or deglycosylation of SP-A had no effect on the stimulation of alveolar macrophages by SP-A. It is concluded that the carbohydrate moiety of SP-A is involved in the recognition of viruses by SP-A and may play a role in the antiviral defenses of the lung.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1334078

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

Review 1.  The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung.

Authors:  Francis X McCormack; Jeffrey A Whitsett
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

Review 2.  Surfactant protein-A: new insights into an old protein--Part I.

Authors:  A R Kumar; J M Snyder
Journal:  Indian J Pediatr       Date:  1998 Sep-Oct       Impact factor: 1.967

3.  Surfactant protein B inhibits secretory phospholipase A2 hydrolysis of surfactant phospholipids.

Authors:  R Duncan Hite; Bonnie L Grier; B Moseley Waite; Ruud A Veldhuizen; Fred Possmayer; Li-Juan Yao; Michael C Seeds
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-10-28       Impact factor: 5.464

Review 4.  Non-Pulmonary Immune Functions of Surfactant Proteins A and D.

Authors:  Sylvia Ujma; William G C Horsnell; Arieh A Katz; Howard W Clark; Georgia Schäfer
Journal:  J Innate Immun       Date:  2016-10-29       Impact factor: 7.349

5.  Binding of host collectins to the pathogenic yeast Cryptococcus neoformans: human surfactant protein D acts as an agglutinin for acapsular yeast cells.

Authors:  S Schelenz; R Malhotra; R B Sim; U Holmskov; G J Bancroft
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

6.  Long-term effects of instilled mineral dusts on pulmonary surfactant isolated from monkeys.

Authors:  C L Schengrund; X Chi; J Sabol; J W Griffith
Journal:  Lung       Date:  1995       Impact factor: 2.584

7.  Surfactant protein D binding to alveolar macrophages.

Authors:  K Miyamura; L E Leigh; J Lu; J Hopkin; A López Bernal; K B Reid
Journal:  Biochem J       Date:  1994-05-15       Impact factor: 3.857

8.  Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses.

Authors:  K L Hartshorn; E C Crouch; M R White; P Eggleton; A I Tauber; D Chang; K Sastry
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

9.  Binding of human collectins (SP-A and MBP) to influenza virus.

Authors:  R Malhotra; J S Haurum; S Thiel; R B Sim
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

10.  Increased expression of surfactant protein A and D in rheumatoid arthritic synovial fluid (RASF).

Authors:  Orhan Kankavi
Journal:  Croat Med J       Date:  2006-02       Impact factor: 1.351

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.